| Structure |
Chemical Name |
CAS |
MF |
 |
Canagliflozin Impurity 25 Complete Set |
|
|
 |
Peramivir Intermediate Impurity 37 |
|
|
 |
Peramivir Diastereomer Impurity 1 |
|
|
 |
Vinpocetine impurity 18 drops |
|
|
 |
Canagliflozin Impurities 999 |
|
|
 |
1,4,8,11-tetraazacyclotetradecane sodium chelation |
|
|
 |
4-Methoxy-2,3,5-trimethylpyride-N-oxide |
86604-80-0 |
C9H13NO2 |
 |
1-BOC-4-(5-NITRO-2-PYRIDYL)PIPERAZINE |
193902-78-2 |
C14H20N4O4 |
 |
Relugolix Impurity 25 |
|
|
 |
Lumateperone Impurity 5 |
|
|
 |
Sugammadex Sodium Impurity ORG139131-1 |
|
|
![2-[4-(Azidomethyl)phenyl]benzoic acid](/) |
2-[4-(Azidomethyl)phenyl]benzoic acid |
|
|
![2-[(2-AZIDOETHOXY)METHYL]-4-(2-CHLOROPHENYL)-3-ETHOXYCARBONYL-5-METHOXYCARBONYL)-6-METHYL-1,4-DIHYDROPYRIDINE](/CAS/GIF/88150-46-3.gif) |
2-[(2-AZIDOETHOXY)METHYL]-4-(2-CHLOROPHENYL)-3-ETHOXYCARBONYL-5-METHOXYCARBONYL)-6-METHYL-1,4-DIHYDROPYRIDINE |
88150-46-3 |
C20H23ClN4O5 |
![((6aR,9R,10aR)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-yl)methanol acetic acid salt](/) |
((6aR,9R,10aR)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-yl)methanol acetic acid salt |
|
|
 |
Brivaracetam Impurity 56 |
|
|
 |
Oxytocin Impurity 3 |
|
|
 |
Rosuvastatin Impurity 158 |
|
|
 |
Rosuvastatin Impurity 139 |
|
|
 |
Rosuvastatin Impurity 124 |
|
|
 |
(1R,4R)-1-(メチルアミノ)-4-(3,4-ジクロロフェニル)テトラリン |
79617-95-1 |
C17H17Cl2N |
 |
Ertapenem Impurity A(USP) |
|
|
![D-Glutamic acid, 4-(cyanomethyl)-N-[(1,1-dimethylethoxy)carbonyl]-, 1,5-dimethyl ester, (4S)-rel-](/CAS/20210305/GIF/2740644-40-8.gif) |
D-Glutamic acid, 4-(cyanomethyl)-N-[(1,1-dimethylethoxy)carbonyl]-, 1,5-dimethyl ester, (4S)-rel- |
2740644-40-8 |
C14H22N2O6 |
![2-hydroxy-3-oxobutyl 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate](/) |
2-hydroxy-3-oxobutyl 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate |
|
|
 |
Ivabradine Bisbenzazepine Analog |
2731089-65-7 |
C27H34N2O6 |
![2-(2-ethoxy-3-((4-ethylpiperazin-1-yl)sulfonyl)phenyl)-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one](/) |
2-(2-ethoxy-3-((4-ethylpiperazin-1-yl)sulfonyl)phenyl)-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one |
|
|
 |
Bumetanide Photodegradable Impurity 15 |
|
|
 |
Bisoprolol Impurity 48 |
|
|
![Cyclopentanecarboxylic acid, 3-[(1S)-1-(acetylamino)-2-ethylbutyl]-4-amino-2-hydroxy-, methyl ester, (1S,2S,3R,4R)-, mono(trifluoroacetate) (salt) (9CI)](/CAS/20211123/GIF/357448-34-1.gif) |
Cyclopentanecarboxylic acid, 3-[(1S)-1-(acetylamino)-2-ethylbutyl]-4-amino-2-hydroxy-, methyl ester, (1S,2S,3R,4R)-, mono(trifluoroacetate) (salt) (9CI) |
357448-34-1 |
C17H29F3N2O6 |
 |
Faropenem Impurity AB |
|
|
 |
Nirmatrelvir Impurity 9 |
|
|
 |
4-nitro-1H-Imidazole-2-carboxaldehyde |
33543-81-6 |
C4H3N3O3 |
 |
1-CHLOROMETHYL-2,3,4-TRIMETHOXYBENZENE |
1133-49-9 |
C10H13ClO3 |
 |
Bumetanide Impurity 19 |
|
|
 |
Rocuronium Bromide Impurity 26 、27 |
|
|
 |
Roxadustat Impurity 20 |
|
|
 |
Ruxolitinib Impurity |
|
|
 |
Sitagliptin Impurity 82 |
|
|
 |
(1S,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran- 2-yl)ethyl)-3,7-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl 2,2-dimethylbutanoate |
|
|
 |
Perospirone Impurity 21 |
|
|
 |
Perospirone Impurity 11 |
|
|
 |
Linagliptin Impurity 43 |
|
|
 |
MiraBegron Impurity A |
|
|
 |
Moxifloxacin Impurity 15 |
|
|
 |
Moxifloxacin Impurity 32 |
|
|
 |
1,4-ジヒドロ-2,6-ジメチル-4-(2-ニトロフェニル)-3,5-ピリジンジカルボン酸3-メチル5-エチル |
53055-15-5 |
C18H20N2O6 |
 |
Olaparib Impurity 15 |
2250243-17-3 |
C24H25FN4O3 |
 |
Olopatadine Impurity 4 |
55690-15-8 |
C18H18O5 |
 |
Posaconazole Impurity 26 |
|
|
 |
Posaconazole Impurity 48 |
1902954-03-3 |
C37H42F2N8O5 |
 |
Posaconazole Impurity 9 |
|
|
 |
Roxithromycin Impurity E |
|
|
 |
SofosBuvir impurity 48 |
|
|
 |
SofosBuvir Impurity 54 |
1431932-81-8 |
C12H17ClNO4P |
 |
Timolol EP Impurity G |
75202-36-7 |
C6H9N3O3S |
 |
Tofacitinib Impurity 44 |
2374700-39-5 |
C13H19N5 |
 |
Trelagliptin Impurity 24 |
|
|
 |
dimethyl 3- isobutylpentanedioate |
145328-03-6 |
C11H20O4 |
![Phenol, 4-chloro-3-[(4-ethoxyphenyl)methyl]-](/CAS/20180601/GIF/1408077-50-8.gif) |
Phenol, 4-chloro-3-[(4-ethoxyphenyl)methyl]- |
1408077-50-8 |
C15H15ClO2 |
![2-amino-9-((3aS,4S,6S,6aR)-3a,6-dihydroxyhexahydro-1H-cyclopenta[c]furan-4-yl)-1,9-dihydro-6H-purin-6-one](/CAS/20180601/GIF/1984788-96-6.gif) |
2-amino-9-((3aS,4S,6S,6aR)-3a,6-dihydroxyhexahydro-1H-cyclopenta[c]furan-4-yl)-1,9-dihydro-6H-purin-6-one |
1984788-96-6 |
C12H15N5O4 |
 |
Ampicillin Impurity C |
|
|
 |
Ampicillin Impurity O |
|
|
![(4R,5R,6S)-4-nitrobenzyl 6-((R)-1-hydroxyethyl)-4-methyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate](/CAS/20180601/GIF/104873-15-6.gif) |
(4R,5R,6S)-4-nitrobenzyl 6-((R)-1-hydroxyethyl)-4-methyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate |
104873-15-6 |
C17H18N2O7 |
 |
Lesinurad Impurity |
|
|
![7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-(5-chloro-2-ethoxyphenyl)-1,6-dihydro-1-methyl-3-propyl-](/CAS/20180601/GIF/1829588-57-9.gif) |
7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-(5-chloro-2-ethoxyphenyl)-1,6-dihydro-1-methyl-3-propyl- |
1829588-57-9 |
C17H19ClN4O2 |
 |
Cefminox sodium impurities Ⅲ |
|
|
 |
Canagliflozin Impurity 18 |
1951467-29-0 |
C24H25FO6S |
 |
Fosaprepitant Impurity 6 |
327623-34-7 |
C21H19F6NO3 |
 |
Ivabradine Impurity 16 HCl |
304464-98-0 |
C26H34N2O5 |
 |
Moxifloxacin EP Impurity A HCl |
|
|
 |
Paroxetine EP Impurity H HCl |
503834-41-1 |
C19H23ClFNO |
 |
Solifenacin Related Compound 13 |
1251905-45-9 |
C17H17NO2 |
![1-(3-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide](/CAS/20180601/GIF/2101651-50-5.gif) |
1-(3-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide |
2101651-50-5 |
C14H12FN5 |
 |
N1-(4-chlorophenyl)-3,12-diimino-N14-phenyl-2,4,11,13-Tetraazatetradecanediimidamide |
152504-12-6 |
C22H31ClN10 |
 |
N-エチル-N-メチルカルバモイルクロリド |
42252-34-6 |
C4H8ClNO |
 |
Cisatracurium-20-methyl Dibenzenesulfonate |
1193104-85-6 |
C60H79N2O15S+ |
![(3S)-N-[(1R)-1-フェニルエチル]-1-アザビシクロ[2.2.2]オクタン-3-アミン二塩酸塩](/CAS/GIF/128311-06-8.gif) |
(3S)-N-[(1R)-1-フェニルエチル]-1-アザビシクロ[2.2.2]オクタン-3-アミン二塩酸塩 |
128311-06-8 |
C15H24Cl2N2 |
 |
GURKHSYORGJETM-MGDILKBHSA-N |
1992961-26-8 |
C33H39ClN4O6 |
 |
DVCUGHHGLKCBMT-QVDQXJPCSA-N |
1356353-76-8 |
C15H24N6O6 |
 |
5,6-Dehydro-Tigecycline |
1633815-62-9 |
C29H37N5O8 |
![2,3,5,6-tetradeuterio-4-[5-[4-(hydroxymethyl)phenyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide](/CAS/20180601/GIF/1276524-56-1.gif) |
2,3,5,6-tetradeuterio-4-[5-[4-(hydroxymethyl)phenyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide |
1276524-56-1 |
C17H10D4F3N3O3S |
 |
1,1-ジフェニル-1-プロパノール |
5180-33-6 |
C15H16O |
 |
(R)-De(trifluoromethyl) Fluoxetine Hydrochloride |
1212215-97-8 |
C16H20ClNO |
![(1R,5S)-1-phenyl-3-oxabicyclo[3.1.0]hexan-2-one](/CAS/20180601/GIF/96847-52-8.gif) |
(1R,5S)-1-phenyl-3-oxabicyclo[3.1.0]hexan-2-one |
96847-52-8 |
C11H10O2 |
![12-ethyl-8-methyl-9-oxo-7-propionyl-9,11-dihydroindolizino[1,2-b]quinolin-2-yl [1,4'-bipiperidine]-1'-carboxylate](/CAS/20180703/GIF/176515-52-9.gif) |
12-ethyl-8-methyl-9-oxo-7-propionyl-9,11-dihydroindolizino[1,2-b]quinolin-2-yl [1,4'-bipiperidine]-1'-carboxylate |
176515-52-9 |
C32H38N4O4 |
 |
4-amino-5-chloro-N-(1-propylpiperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide |
|
C17H24ClN3O2 |
 |
Ceftazidime Impurity D |
|
|
 |
Ceftazidime Sulfoxide Impurity |
|
|
 |
Tofacitinib Impurity Y |
|
|
 |
5-amino-6-chloro-2-(propylthio)pyrimidin-4-ol |
|
C7H10ClN3OS |
 |
Landiolol impurity K |
190601-22-0 |
C19H29N3O6 |
 |
Crisaborole Impurity |
906673-42-5 |
C14H10BNO3 |
 |
Olanzapine impurity N |
|
C17H20N4S |
 |
Cabozantinib impurity 25 |
|
|
 |
Vildagliptin Impurity 39 |
|
|
 |
Tazobactam Impurity D |
|
|
 |
Palonosetron Impurity 22 |
1217547-14-2 |
C19H24N2O2 |
 |
Pitavastatin Impurity 35 |
|
|
 |
Pralatrexate Impurity 15 |
|
|
 |
Pitavastatin Impurity 52 |
|
|
 |
Pitavastatin Impurity 60 |
1661064-71-6 |
C25H22FNO3 |